Clinical trial
Effectiveness and Handling of Spiolto® Respimat ® in COPD Patients - Italy
NCT03003494 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effectiveness and Handling of Spiolto® Respimat ® in COPD Patients - Italy
- Lead sponsor
- Boehringer Ingelheim
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 6, 2017
- Completion date
- July 30, 2018
- Enrollment
- 306 (actual)
- Sites
- 28
Conditions
As the registry lists them; a condition with its own page is linked.